|
|
|
NARFE April
We are happy to announce that registration for the 2021 Alzheimer's Impact Movement (AIM) Advocacy Forum is now open. Held virtually this year, the Advocacy Forum is the nation's premier Alzheimer's advocacy event. We invite all NARFE members to join us on May 19 at 7 p.m. ET to hear from policymakers, Celebrity Champions, Association leadership and more. During the program, we'll honor this year's AIM Humanitarian of the Year congressional awardees, share the latest information on our federal policy priorities, and discuss how our policy victories are making a difference in the lives of people facing Alzheimer's. The generosity of NARFE and its members helps make possible our efforts in the fight to end Alzheimer's. We are so grateful for your support. Register today at alz.com/forum.
|
|
|
Cancer drug shows promise for treating Alzheimer's
The cancer drug sargramostim may improve memory and thinking in people living with mild-to-moderate Alzheimer's disease, according to a small pilot study published in Alzheimer's & Dementia: Translational Research & Clinical Interventions. While experts caution the research is preliminary, participants showed a reversal of brain damage associated with Alzheimer's, as well as improved memory and thinking ability. The Alzheimer's Association is supporting the study through the Part the Cloud grant-funding program. Learn more.
|
|
|
|
Alzheimer's may have an effect on relationships
As a caregiver for someone living with Alzheimer's, your relationship with your spouse or partner will change as the disease progresses. But you can prepare for this change and find meaningful ways to connect. Learn more.
|
|
|
|
You may be able to influence some Alzheimer's risk factors
Scientists say factors such as genetics, lifestyle and environment increase the risk of developing Alzheimer's. Some risk factors, such as age, family history and heredity, can't be changed, but emerging evidence suggests there may be other factors we can influence. Learn more.
|
|
|
|
Middle stages of Alzheimer's present challenges
The middle stages of Alzheimer's are typically the longest and can last for many years. We have resources to help caregivers and people living with dementia navigate challenges as the disease progresses. Learn more.
|
|
|
|
View Past Issues
|
|
|
|
NARFE 2022 Goal: $14 Million
|
|
|
24/7 Helpline: 1-800-272-3900
|
|